<DOC>
	<DOC>NCT00689494</DOC>
	<brief_summary>Measure blood progesterone by using cervical device contraception.</brief_summary>
	<brief_title>Cervical Device Contraception-2 (Nanopaz)</brief_title>
	<detailed_description>A very small cervical device that releases small amount of progesterone 20 mcgm/day. The target of the research is to measure blood progesterone by using the cervical device. This small device delivers progesterone by nanotechnology method.</detailed_description>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>10 healthy women are candidate for hysterectomy Women with neoplastic malignancy disease or thrombophylia</criteria>
	<gender>Female</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>2 Months</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Nanopaz device</keyword>
	<keyword>Blood progesterone measure in using the device</keyword>
	<keyword>Delivery progesterone</keyword>
	<keyword>Progesterone levonorgestrel</keyword>
</DOC>